Wealth Enhancement Advisory Services, LLC Adagio Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 16,321 shares of ADGI stock, worth $54,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,321Holding current value
$54,022% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADGI
# of Institutions
82Shares Held
67.7MCall Options Held
31.6KPut Options Held
54.3K-
Mithril Ii Gp LP Austin, TX11.2MShares$37.2 Million46.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11MShares$36.3 Million0.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.72MShares$32.2 Million1.13% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million32.33% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...